Analyst Ratings for Acer Therapeutics (ACER) [Buys]
ACER Rating Summary
ACER Price Target Summary
- Highest: $1.50 (Roth/MKM)
- Lowest: $1.50 (Roth/MKM)
- Average: $1.50
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.50 (+66.7%)
* Over Last 12-Mos
Rating Score: 2.9 / 10 Percentile Rank: 24%
Rating Score: 2.9 / 10 Percentile Rank: 24%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/23/2019 | Wedbush » Updated 6/25/2019 |
Laura Chico | New Coverage | Outperform (N/A) |
8.00 (48.00) |
19.71 (0.90) |
-95.43% | Details |
12/7/2017 | Brookline Capital Markets » Updated 8/15/2018 |
Kumaraguru Raja | New Coverage | Buy (N/A) |
51.00 (N/A) |
14.81 (0.90) |
-93.92% | Details |